As part of our routine safety review process for Mounjaro (tirzepatide) and Zepbound (tirzepatide) we have ongoing discussions with regulators regarding potential safety topics, and we will continue to review data, including any data regarding ophthalmic issues
Lotte Bjerre Knudsen (23:19): Yes
Management of post-bariatric hypoglycaemia follows a stepwise approach , beginning with dietary modification and progressing to pharmacological and, rarely, surgical interventions for refractory cases
Over time, this chronic inflammation damages the thyroid, leading to hypothyroidismor underactive thyroid function
Ania Jastreboff, an obesity medicine physician scientist at Yale University School of Medicine/Yale School of Medicine, co-Director of the Yale Center for Weight Management and the lead author on the phase 2 study, said that the results were striking and concluded that Retatrutide holds promise for substantial weight reduction in adults with obesity over a 48-week period